Literature DB >> 23778805

Regulation unmasked by activation.

Mike Clark1, Anne Cooke.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23778805     DOI： 10.1038/ni.2646

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  10 in total

Review 1.  Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?

Authors:  Huan Cao; Paul R Crocker
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

2.  Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation.

Authors:  N Razi; A Varki
Journal:  Glycobiology       Date:  1999-11       Impact factor: 4.313

Review 3.  Siglecs and their roles in the immune system.

Authors:  Paul R Crocker; James C Paulson; Ajit Varki
Journal:  Nat Rev Immunol       Date:  2007-04       Impact factor: 53.106

4.  Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis.

Authors:  M Q Xia; G Hale; M R Lifely; M A Ferguson; D Campbell; L Packman; H Waldmann
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

5.  Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes.

Authors:  W C Rowan; G Hale; J P Tite; S J Brett
Journal:  Int Immunol       Date:  1995-01       Impact factor: 4.823

6.  Primary structure of CD52.

Authors:  A Treumann; M R Lifely; P Schneider; M A Ferguson
Journal:  J Biol Chem       Date:  1995-03-17       Impact factor: 5.157

7.  T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10.

Authors:  Esther Bandala-Sanchez; Yuxia Zhang; Simone Reinwald; James A Dromey; Bo-Han Lee; Junyan Qian; Ralph M Böhmer; Leonard C Harrison
Journal:  Nat Immunol       Date:  2013-05-19       Impact factor: 25.606

8.  Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate.

Authors:  Elina Kivi; Kati Elima; Kristiina Aalto; Yvonne Nymalm; Kaisa Auvinen; Erkki Koivunen; Diana M Otto; Paul R Crocker; Tiina A Salminen; Marko Salmi; Sirpa Jalkanen
Journal:  Blood       Date:  2009-10-27       Impact factor: 22.113

9.  CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.

Authors:  Guo-Yun Chen; Jie Tang; Pan Zheng; Yang Liu
Journal:  Science       Date:  2009-03-05       Impact factor: 47.728

Review 10.  Alemtuzumab therapy for multiple sclerosis.

Authors:  Alasdair J Coles
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620
  10 in total
  1 in total

Review 1.  Impact of Immune-Modulatory Drugs on Regulatory T Cell.

Authors:  Akiko Furukawa; Steven A Wisel; Qizhi Tang
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.